Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited
Abdominal Ultrasound

Clinical and contrast-enhanced ultrasound characteristics of hepatocellular adenoma

  • Minhong Zou 1 ,
  • Qing Huang 1 ,
  • Ye Jiang 2 ,
  • Luanjing Zhuang 3 ,
  • Rongqin Zheng , 1,
Expand
  • 1.Department of Ultrasound, the Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510630, China
  • 2.Department of Pathology, the Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510630, China
  • 3.Department of Gastrointestinal Surgery, Guangzhou First People's Hospital (The Second Affiliated Hospital of South China University of Technology), Guangzhou 510013, China
Corresponding author: Zheng Rongqin, Email:

Received date: 2021-07-06

  Online published: 2023-01-19

Copyright

Copyright by Chinese Medical Association No content published by the journals of Chinese Medical Association may be reproduced or abridged without authorization. Please do not use or copy the layout and design of the journals without permission. All articles published represent the opinions of the authors, and do not reflect the official policy of the Chinese Medical Association or the Editorial Board, unless this is clearly specified.

Abstract

Objective

To summarize the clinical and ultrasound characteristics of hepatocellular adenoma to improve its diagnosis.

Methods

The clinical, imaging, and pathological data of 10 patients with hepatic adenoma (HCA group), 17 patients with hepatic angiomyolipoma (CMAL group), and 40 randomly selected AFP negative hepatocellular carcinoma patients (HCC (AFP-) group) diagnosed at the Third Affiliated Hospital of Sun Yat-sen University from January 2008 to May 2021 were retrospectively reviewed. The t-test and chi-square test were used to compare the clinical characteristics and ultrasound and contrast-enhanced ultrasound findings in the three groups.

Results

The average age of onset in the HCA group was (36.40±16.68) years old. The gender (male/female: 5/5 vs 36/4) and hepatitis virus infection status (yes/no: 0/10 vs 40/0) of the patients in the HCA group (yes/no: 0/10 vs 40/0) were statistically different from those of the HCC (AFP-) group (χ2=8.672, P=0.010; χ2=50.000, P<0.001), but showed no statistical difference from those of the CAML group (P>0.05 for all). There were statistically significant differences in tumor echo between the HCA (unspecific tumor echo) and HCC (AFP-) (mostly hypoechoic) groups (χ2=8.404, P=0.011), though there was no significant difference in tumor number, size, morphology, or blood supply (P>0.05 for all). There was also no significant difference in tumor number, size, boundary, echo, morphology, or blood supply of lesions between the HCA and CAML groups (P>0.05 for all). The CEUS pattern was mainly "hyperintense-isointense-isointense" for HCA lesions, "hyperintense-hypointense-hypointense" for HCC (AFP-) lesions, and "hyperintense-hyperintense-isointense" or "hyperintense-isointense-isointense" for CAML lesions. The CEUS pattern between the HCA group and the CAML group was not statistically different. There was a statistically significant difference in the enhancement patter in the portal phase (hyperintense/isointense/hypointense: 1/6/3 vs 0/4/36; χ2=15.106, P<0.001) and the delayed phase (hyperintense/isointense/hypointense: 0/6/4 vs 0/1/39; χ2=12.500, P=0.002) between the HCA group and the HCC (AFP-) group, but there was no statistically significant difference in the arterial phase (P>0.05).

Conclusion

Hepatic adenoma has certain clinical, conventional two-dimensional ultrasound, and contrast-enhanced ultrasound features. Attention should be paid to the possibility of hepatic adenoma in women, patients without hepatitis B infection and those with a "hyperintense-isointense-isointense" pattern on CEUS.

Cite this article

Minhong Zou , Qing Huang , Ye Jiang , Luanjing Zhuang , Rongqin Zheng . Clinical and contrast-enhanced ultrasound characteristics of hepatocellular adenoma[J]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2022 , 19(11) : 1225 -1231 . DOI: 10.3877/cma.j.issn.1672-6448.2022.11.012

1
Bonder A, Afdhal N. Evaluation of liver lesions [J]. Clin Liver Dis, 2012, 16(2): 271-283.

2
Dietrich CF, Tannapfel A, Jang HJ, et al. Ultrasound imaging of hepatocellular adenoma using the new histology classification [J]. Ultrasound Med Biol, 2019, 45(1): 1-10.

3
Lo RC. Epithelioid angiomyolipoma of the liver: a clinicopathologic study of 5 cases [J]. Ann Diagn Pathol, 2013, 17(5): 412-415.

4
Zou MH, Huang Q, Zou Q, et al. Clinical and contrast-enhanced ultrasound characteristics of epithelioid and classic hepatic angiomyolipoma: comparison with alpha-fetoprotein-negative hepatocellular carcinoma [J]. Ultrasound Med Biol, 2021, 47(3): 446-453.

5
陈凯玲, 张炜彬, 毛枫, 等. 超声造影诊断炎症型肝细胞腺瘤的临床应用 [J]. 中华超声影像学杂志, 2021, 30(1): 48-53.

6
Huang WC, Liau JY, Jeng YM, et al. Hepatocellular adenoma in taiwan: distinct ensemble of male predominance, overweight/obesity, and inflammatory subtype [J]. J Gastroenterol Hepatol, 2020, 35(4): 680-688.

7
Nault JC, Paradis V, Cherqui D, et al. Molecular classification of hepatocellular adenoma in clinical practice [J]. J Hepatol, 2017, 67(5): 1074-1083.

8
Socas L, Zumbado M, Perez-Luzardo O, et al. Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature [J]. Br J Sports Med, 2005, 39(5): e27.

9
Mouhoub M, Miry A, Haloui A, et al. Malignant transformation of hepatocellular adenoma: report of a case [J]. Pan Afr Med J, 2020, 35: 92.

10
Dhingra S, Fiel MI. Update on the new classification of hepatic adenomas: clinical, molecular, and pathologic characteristics [J]. Arch Pathol Lab Med, 2014, 138(8): 1090-1097.

11
Nault J, Couchy G, Balabaud C, et al. Molecular classification of hepatocellular adenoma associates with risk factors, bleeding, and malignant transformation [J]. Gastroenterology, 2017, 152(4): 880-894.

12
杨秋霞, 张嵘, 吴静, 等. 肝细胞腺瘤的影像学表现与组织病理学的相关性 [J]. 中国CT和MRI杂志, 2013, 11(1): 48-52, 71.

13
Lee SJ, Kim SY, Kim KW, et al. Hepatic angiomyolipoma versus hepatocellular carcinoma in the noncirrhotic liver on gadoxetic acid-enhanced mri: a diagnostic challenge [J]. AJR Am J Roentgenol, 2016, 207(3): 562-570.

14
Sandulescu L, Saftoiu A, Dumitrescu D, et al. Real-time contrast-enhanced and real-time virtual sonography in the assessment of benign liver lesions [J]. J Gastrointestin Liver Dis, 2008, 17(4): 475-478.

15
Garcovich M, Faccia M, Meloni F, et al. Contrast-enhanced ultrasound patterns of hepatocellular adenoma: an italian multicenter experience [J]. J Ultrasound, 2019, 22(2): 157-165.

16
Dietrich CF, Nolsoe CP, Barr RG, et al. Guidelines and good clinical practice recommendations for contrast-enhanced ultrasound (ceus) in the liver-update 2020 wfumb in cooperation with efsumb, afsumb, aium, and flaus [J]. Ultrasound Med Biol, 2020, 46(10): 2579-2604.

Outlines

/

Copyright © Chinese Journal of Medical Ultrasound (Electronic Edition), All Rights Reserved.
Tel: 010-51322630、2632、2628 Fax: 010-51322630 E-mail: csbjb@cma.org.cn
Powered by Beijing Magtech Co. Ltd